ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

BCTX BriaCell Therapeutics Corporation

1.43
-0.05 (-3.38%)
最終更新日: 23:27:32
15分遅延
名称 銘柄コード 市場 種別
BriaCell Therapeutics Corporation BCTX NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
-0.05 -3.38% 1.43 23:27:32
始値 安値 高値 終値 前日終値
1.51 1.43 1.51 1.48
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/6/0321:00GLOBEBriaCell Presents Clinical Efficacy Data at ASCO 2024
2024/5/3021:00GLOBEBriaCell Initiates Patient Enrollment in First-in-Human..
2024/5/2821:00GLOBEBriaCell Announces Clinical Supply Agreement with BeiGene..
2024/5/2421:00GLOBEBriaCell Doubles Progression-Free-Survival (PFS) and Reports..
2024/5/1805:33GLOBEBriaCell Therapeutics Announces Closing of $5.0 Million..
2024/5/1521:00GLOBEBriaCell Therapeutics Announces Pricing of $5.0 Million..
2024/4/2421:00GLOBEBriaCell Announces Oral and Poster Presentations at ASCO..
2024/4/1021:00GLOBEBriaCell 2024 AACR Preclinical Poster Confirms Strong..
2024/4/0921:00GLOBEBriaCell Showcases Data Demonstrating Unmatched..
2024/3/0722:00GLOBEBriaCell Receives and Executes Letter of Intent to Advance..
2024/3/0622:00GLOBEBriaCell to Present Clinical Data in Central Nervous System..
2024/2/2722:00GLOBEBriaCell Provides Update on Alleged Illegal Trading of..
2024/2/0722:00GLOBEBriaCell Announces Strong Clinical Data in Breast Cancer..
2024/2/0622:30GLOBEBreaking Ground in Prostate Cancer: BriaCell Announces Lead..
2024/2/0114:15EDGAR2Form EFFECT - Notice of Effectiveness
2024/2/0107:24EDGAR2Form 8-K - Current report
2024/1/3112:48GLOBEBriaCell Therapeutics Corp. Announces Results of Shareholder..
2024/1/2307:00EDGAR2Form S-3 - Registration statement under Securities Act of..
2024/1/1006:05EDGAR2Form DEF 14A - Other definitive proxy statements
2024/1/0422:45GLOBEBriaCell Images Confirm Robust Anti-Tumor Activity in..
2023/12/2822:55GLOBEBriaCell Reports 71% Central Nervous System Response Rate in..
2023/12/2106:05EDGAR2Form 8-K - Current report
2023/12/2022:40GLOBEBriaCell Reports Unprecedented Preliminary Survival and..
2023/12/1507:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/12/1507:00EDGAR2Form 8-K - Current report
2023/12/0623:31GLOBEBriaCell Highlights Outstanding Topline Survival and..
2023/12/0623:00GLOBEBriaCell 2023 SABCS Posters Confirm Activation of..
2023/11/3021:00EDGAR2Form 8-K - Current report
2023/11/3021:00GLOBEBriaCell Records New Responder with Remarkable Improvement..
2023/11/0321:31GLOBEBriaCell Reports Unprecedented Anti-Tumor Activity of its..
2023/10/2522:15GLOBEBriaCell Forms Medical Advisory Board of Distinguished..
2023/10/2022:15GLOBEOctober is Breast Cancer Awareness Month – BriaCell is..
2023/10/1822:00GLOBEBriaCell Announces Presentations at the 2023 Society for the..
2023/10/1122:10GLOBEBriaCell To Host Virtual Key Opinion Leader Event on..
2023/10/0422:00GLOBEBriaCell Partners with New York Cancer & Blood Specialists..
2023/10/0322:00GLOBEBriaCell Initiates Pivotal Phase 3 Study of Bria-IMT™ in..
2023/9/0820:00GLOBEBriaCell Reports Benchmark-Beating Patient Survival and..
2023/9/0100:54GLOBEBriaCell Therapeutics Corp. Announces Closing of Plan of..
2023/8/3121:21GLOBEBriaCell Accepts Letter of Intent from Weill Cornell..
2023/8/2603:33GLOBEBriaCell Receives Court Approval for the Share Arrangement..
2023/8/1901:21GLOBEBriaCell Therapeutics Corp. Announces Voting Results From..
2023/8/1621:36GLOBEBriaCell Awarded National Cancer Institute Grant to Advance..
2023/6/2722:37APSNews Brief: BriaCell Therapeutics Corp.
2023/6/2721:05GLOBEFDA Approves BriaCell’s Pivotal Registrational Study Design..

最近閲覧した銘柄

Delayed Upgrade Clock